Wallace Advisory Group’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1,100
Closed -$208K 145
2026
Q1
$208K Sell
1,100
-175
-14% -$36.9K 0.22% 120
2025
Q4
$253K Sell
1,275
-1,419
-53% -$287K 0.27% 105
2025
Q3
$474K Buy
2,694
+1,059
+65% +$188K 0.38% 79
2025
Q2
$220K Buy
+1,635
New +$246K 0.16% 162

Other funds holding THC

Wallace Advisory Group's THC Position: Q2 2026 in Review

Wallace Advisory Group sold out of Tenet Healthcare (THC) in Q2 2026, closing a stake of 1,100 shares — an estimated $208K sold.

Wallace Advisory Group first reported a position in THC in Q2 2025 and held it in 4 quarters. The position peaked at $474K in Q3 2025. 679 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • Wallace Advisory Group reported no remaining Tenet Healthcare position as of Q2 2026 after selling out during the quarter.
  • Wallace Advisory Group sold 1,100 Tenet Healthcare shares in Q2 2026, an estimated $208K.
  • Wallace Advisory Group first reported a position in Tenet Healthcare in Q2 2025 and held it in 4 quarters.
  • Wallace Advisory Group's Tenet Healthcare position peaked at $474K in Q3 2025.
  • 679 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on Wallace Advisory Group's 13F filing for Q2 2026, filed 3 Aug 2026.